Biognosys
Newton, MA, United States biognosys.com
From their website, Nov 2026
Work here? Claim this listing
About
Biognosys provides proteomics contract research services, software, kits, and sample preparation reagents for pharma, biotech, and clinical research customers. It operates laboratories in Boston, Massachusetts, and Zurich, Switzerland, and supports drug discovery, translational research, and clinical development.
Services
Discovery proteomics
Generates deep, quantitative proteome profiles to support biomarker discovery and exploratory studies using mass spectrometry workflows and data analysis.
Clinical and targeted proteomics
Provides multiplexed, peptide-resolved quantitative protein measurements for translational research and clinical trials, including assay design and validation.
Chemoproteomics
Delivers proteome-wide mechanistic insights for small-molecule drug discovery, including target deconvolution and mechanism-of-action studies.
Immunopeptidomics
Supports proteome-scale analysis of immunopeptides for research applications.
Data solutions
Provides data analysis and interpretation services for proteomics projects.
NULISA proteomics assay services
Offers NULISA multiplex assay services for biomarker discovery in plasma and other biofluids.
Metabolomics and lipidomics services
Provides quantitative metabolomics and lipidomics services for multiomics drug discovery and clinical/translational research.
Spectronaut software
Software for DIA proteomics analysis.
SpectroMine software
Software for DDA proteomics analysis.
SpectroDive software
Software for targeted proteomics analysis.
QuiC software
Free QC tool for proteomics workflows.
PQ500 reference peptides
Reference peptide kit for quantification of more than 500 proteins in human plasma/serum samples.
iRT kit
Retention time normalization kit for time-resolved mass spectrometry, for up to 500 injections.
- What to send
- 10 ul of plasma or other biofluids for NULISA services
- Minimums and prices
- PQ500™ Reference Peptides: 3'250.00 $ – 9'750.00 $
Capabilities
- Assays and studies
- Peptides · LC-MS/MS · Small molecules · DIA proteomics · DDA proteomics · Targeted proteomics · SISCAPA-based immune-enrichment · LC-MS analysis · Mass spectrometry-based proteomics · LiP-MS · NULISA multiplex assays
- Scale and capacity
- Thousands of proteins · Thousands of samples · More than 500 proteins
- Therapeutic areas
- Disease biomarker research · Cancer · Inflammation · CNS disease · Drug discovery · Clinical research
Instruments and platforms
- ARGO HT System
- Bruker EVOQ DART-TQ+ mass spectrometer
Modalities and species
- Modalities
- Small molecule · Antibody · Peptide · Cell therapy
- Species and models
- Human plasma · Serum · CSF · Tissue · Biofluids
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: lab operation services
Company
- Type
- CRO
- Founded
- 2017
- Quality
- GCP-compliant (clinical studies) · GLP-like (lab operation services) · validated workflow (metabolomics/lipidomics services)
Locations
- Address
- Wagistrasse 21 8952 Schlieren Switzerland
- Sites
- Boston, United States · Zurich, Switzerland
- Serves
- Europe, United States, global
Similar labs
Work here? Claim this listing